US5160744A
(en)
*
|
1991-06-27 |
1992-11-03 |
Alza Corporation |
Verapmil therapy
|
US6764697B1
(en)
*
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
GB9117361D0
(en)
*
|
1991-08-12 |
1991-09-25 |
Euro Celtique Sa |
Oral dosage form
|
FI93924C
(fi)
*
|
1991-09-17 |
1995-06-26 |
Martti Lauri Antero Marvola |
Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
|
US5422122A
(en)
*
|
1992-08-04 |
1995-06-06 |
Eurand America, Incorporated |
Controlled release potassium chloride tablet
|
RU2121830C1
(ru)
*
|
1992-09-18 |
1998-11-20 |
Яманоути Фармасьютикал Ко., ЛТД |
Гидрогелевый препарат с длительным высвобождением лекарства
|
PT621032E
(pt)
*
|
1993-04-23 |
2001-01-31 |
Novartis Ag |
Dispositivo de distribuicao de libertacao controlada de farmaco
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US5922736A
(en)
*
|
1995-12-04 |
1999-07-13 |
Celegene Corporation |
Chronic, bolus administration of D-threo methylphenidate
|
US6486177B2
(en)
*
|
1995-12-04 |
2002-11-26 |
Celgene Corporation |
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
US6096339A
(en)
*
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
WO1998023263A1
(en)
*
|
1996-11-25 |
1998-06-04 |
Alza Corporation |
Ascending-dose dosage form
|
EP1782798A3
(de)
|
1996-11-25 |
2008-05-21 |
Alza Corporation |
Darreichungsform mit ansteigender Dosisfreisetzung
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
IT1291652B1
(it)
*
|
1997-04-24 |
1999-01-19 |
Apr Trading Sa |
Composizioni farmaceutiche a copertura terapeutica programmata
|
US6962997B1
(en)
*
|
1997-05-22 |
2005-11-08 |
Celgene Corporation |
Process and intermediates for resolving piperidyl acetamide steroisomers
|
DE19747261A1
(de)
*
|
1997-10-25 |
1999-04-29 |
Bayer Ag |
Osmotisches Arzneimittelfreisetzungssystem
|
US8524277B2
(en)
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US5945123A
(en)
*
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
KR100827254B1
(ko)
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
WO2000004891A2
(en)
*
|
1998-07-21 |
2000-02-03 |
Alpenstock Holdings Limited |
Anti-ulcer composition
|
US6322819B1
(en)
|
1998-10-21 |
2001-11-27 |
Shire Laboratories, Inc. |
Oral pulsed dose drug delivery system
|
CZ303495B6
(cs)
|
1998-11-02 |
2012-10-24 |
Elan Pharma International Limited |
Mnohocásticový modifikovane uvolnující prostredek a jeho použití, pevná orální dávkovací forma
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
US6387403B1
(en)
|
1999-09-15 |
2002-05-14 |
Alza Corporation |
Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
|
US6610674B1
(en)
*
|
1999-09-28 |
2003-08-26 |
University Of Pennsylvania |
Method of treating inflammatory conditions with progesterone analogs
|
HU230828B1
(en)
|
1999-10-29 |
2018-08-28 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
BR0016708A
(pt)
*
|
1999-12-23 |
2002-10-08 |
Pfizer Prod Inc |
Forma de dosagem de droga baseada em hidrogel
|
JP2003518487A
(ja)
|
1999-12-23 |
2003-06-10 |
ファイザー・プロダクツ・インク |
ヒドロゲル駆動型積層薬物製剤
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
HU230875B1
(hu)
*
|
2000-10-30 |
2018-11-29 |
Euro-Celtique S.A. |
Szabályozott hatóanyag-leadású hidrokodon készítmények
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
WO2003005951A2
(en)
*
|
2001-07-10 |
2003-01-23 |
Teva Pharmaceutical Industries Ltd. |
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
|
US6863901B2
(en)
*
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
US6827946B2
(en)
*
|
2001-12-05 |
2004-12-07 |
Collegium Pharmaceutical, Inc. |
Compositions containing both sedative and non-sedative antihistamines
|
WO2003051341A1
(en)
*
|
2001-12-18 |
2003-06-26 |
Alza Corporation |
Dosage form for providing time-varying patterns of drug delivery
|
US20040052843A1
(en)
*
|
2001-12-24 |
2004-03-18 |
Lerner E. Itzhak |
Controlled release dosage forms
|
EA006053B1
(ru)
*
|
2001-12-24 |
2005-08-25 |
Тева Фармасьютикал Индастриес Лтд. |
Твёрдая лекарственная форма, способ её изготовления и устройство
|
NZ536252A
(en)
*
|
2002-04-29 |
2007-06-29 |
Alza Corp |
Methods and dosage forms for controlled delivery of oxycodone
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
NZ536693A
(en)
*
|
2002-05-31 |
2007-01-26 |
Alza Corp |
Controlled release dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20040005359A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Cheng Xiu Xiu |
Controlled release oral dosage form
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
US20050208132A1
(en)
*
|
2002-07-29 |
2005-09-22 |
Gayatri Sathyan |
Methods and dosage forms for reducing side effects of benzisozazole derivatives
|
EP1534238A1
(de)
*
|
2002-07-29 |
2005-06-01 |
ALZA Corporation |
Formulierungen und dosierformen fuer die kontrollierte abgabe von topiramat
|
ATE373472T1
(de)
*
|
2002-07-29 |
2007-10-15 |
Alza Corp |
Verfahren und dosierformen für die kontrollierte abgabe von paliperidon
|
DE60326731D1
(de)
*
|
2002-07-31 |
2009-04-30 |
Phafag Ag |
Arzneizubereitung und deren anwendung zur behandlu
|
US6913768B2
(en)
*
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
AU2003299659A1
(en)
|
2002-12-13 |
2004-07-09 |
Durect Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
US8293799B2
(en)
*
|
2003-12-29 |
2012-10-23 |
Osmotica Keresleedelmo és Szolgáltató KFT |
Osmotic device containing a venlafaxine salt and a salt having an ion in common
|
US20070077301A1
(en)
*
|
2002-12-23 |
2007-04-05 |
Meyer Glenn A |
Venlafaxine osmotic device formulation
|
JP2006522016A
(ja)
*
|
2003-01-14 |
2006-09-28 |
アルザ・コーポレーシヨン |
改変された粘度の層を用いる方法および投薬形態物
|
JP2006517593A
(ja)
*
|
2003-02-11 |
2006-07-27 |
アルザ・コーポレーシヨン |
投薬形態物の層形状修飾方法およびそのような修飾を受けさせた投薬形態物
|
US7632521B2
(en)
*
|
2003-07-15 |
2009-12-15 |
Eurand, Inc. |
Controlled release potassium chloride tablets
|
CA2534920A1
(en)
*
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
US20050136108A1
(en)
*
|
2003-08-22 |
2005-06-23 |
Yam Noymi V. |
Stepwise delivery of topiramate over prolonged period of time
|
WO2005020959A2
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
CA2540050A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Nishit B. Modi |
Osmotic dosage forms for controlled delivery of alprazolam
|
EP1708684A2
(de)
|
2003-09-26 |
2006-10-11 |
Alza Corporation |
Arzneimittelbeschichtung mit hoher arzneimittelbeladung und verfahren dafür
|
US20050158382A1
(en)
*
|
2003-09-26 |
2005-07-21 |
Evangeline Cruz |
Controlled release formulations of opioid and nonopioid analgesics
|
KR101169614B1
(ko)
|
2003-09-26 |
2012-08-03 |
알자 코포레이션 |
상승한 방출 속도를 나타내는 제어 방출 제제
|
US20060094782A9
(en)
*
|
2003-10-31 |
2006-05-04 |
Wong Patrick S |
Compositions and dosage forms for enhanced absorption
|
AU2004308973A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
WO2005065648A2
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc., |
Novel drug compositions and dosage forms of topiramate
|
MXPA06007509A
(es)
*
|
2003-12-29 |
2007-10-18 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas.
|
US20050239830A1
(en)
*
|
2004-04-26 |
2005-10-27 |
Vikram Khetani |
Methods of diminishing co-abuse potential
|
US20050287213A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Wong Patrick S |
Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
CN101076248A
(zh)
*
|
2004-12-09 |
2007-11-21 |
塞尔基因公司 |
使用d-苏型哌甲酯的治疗
|
CA2596029A1
(en)
*
|
2005-01-27 |
2006-08-03 |
David E. Edgren |
Oral osmotic dosage form having a high flux membrane
|
JP2008536928A
(ja)
*
|
2005-04-19 |
2008-09-11 |
アルザ・コーポレーシヨン |
トラマドール及び、ガバペンチンを含んでなる物質、の組み合わせ物
|
WO2007002872A2
(en)
*
|
2005-06-29 |
2007-01-04 |
Alza Corporation |
Semi-permeable compositions providing reduced drying time for osmotic dosage forms
|
WO2007106111A2
(en)
*
|
2005-07-01 |
2007-09-20 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising nilvadipine
|
JP2009507774A
(ja)
*
|
2005-08-04 |
2009-02-26 |
アルザ・コーポレーシヨン |
改良された性質を提供するポリマー混合物による半透過性膜を含んでなる浸透性用量形態物
|
US8778395B2
(en)
*
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
US20070190137A1
(en)
*
|
2005-10-07 |
2007-08-16 |
Reyes Iran |
Osmotic dosage form with controlled release and fast release aspects
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
DK2018160T3
(da)
|
2006-03-16 |
2012-02-06 |
Tris Pharma Inc |
Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
|
TW200815045A
(en)
*
|
2006-06-29 |
2008-04-01 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of ropinirole and methods of use thereof
|
US20110086092A1
(en)
*
|
2006-08-08 |
2011-04-14 |
Accu-Break Technologies, Inc. |
Pharmacuetical tablets containing a plurality of active ingredients
|
US20090011018A1
(en)
*
|
2006-12-28 |
2009-01-08 |
Astellas Pharma Inc., |
Sustained release formulation for tacrolimus
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
EP2120945A1
(de)
*
|
2007-02-28 |
2009-11-25 |
Collegium Pharmaceutical, Inc. |
Antihistamin-kombination
|
WO2009075782A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
WO2009137827A2
(en)
*
|
2008-05-09 |
2009-11-12 |
Tiara Pharmaceuticals, Inc. |
Controlled release of n-acetylcysteine (nac) for reduction of systemic and/or vascular inflammation
|
US20110130434A1
(en)
*
|
2008-07-30 |
2011-06-02 |
Panacea Biotec Ltd. |
Modified release ramipril compositions and uses thereof
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
WO2010077925A2
(en)
|
2008-12-16 |
2010-07-08 |
Teva Pharmaceutical Industries Ltd. |
Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate
|
US8568793B2
(en)
*
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
US9005661B2
(en)
|
2009-09-15 |
2015-04-14 |
Beijing Team Hospital Management Co., Ltd. |
Osmotic pump controlled release tablet and preparation method thereof
|
CA2789307A1
(en)
*
|
2010-03-29 |
2011-10-06 |
Hetero Research Foundation |
Stable pharmaceutical composition of imatinib
|
EP2554168B1
(de)
|
2010-03-29 |
2018-01-24 |
Astellas Pharma Inc. |
Pharmazeutische zusammensetzung mit kontrollierter freisetzung
|
US8287903B2
(en)
|
2011-02-15 |
2012-10-16 |
Tris Pharma Inc |
Orally effective methylphenidate extended release powder and aqueous suspension product
|
CA2859241C
(en)
*
|
2012-01-17 |
2019-01-29 |
Croda, Inc. |
Seal swell additive comprising sorbitol diester
|
BR112015003120B1
(pt)
|
2012-08-15 |
2022-08-09 |
Tris Pharma , Inc |
Tablete mastigável de liberação estendida de metilfenidato e seu uso
|
EP2983468A4
(de)
|
2013-03-15 |
2016-09-07 |
Durect Corp |
Zusammensetzungen mit rheologiemodifikator zur reduzierung der auflösungsvariabilität
|
CA2902911C
(en)
|
2014-10-31 |
2017-06-27 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
US11590228B1
(en)
|
2015-09-08 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine compositions
|
US9707217B1
(en)
|
2017-02-03 |
2017-07-18 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dose-dumping resistant controlled release dosage form
|
US11590081B1
(en)
|
2017-09-24 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine tablets
|
AU2019221765A1
(en)
|
2018-02-16 |
2020-09-10 |
Esperion Therapeutics, Inc. |
Sustained release formulations of bempedoic acid
|
ES2909803T3
(es)
*
|
2018-03-05 |
2022-05-10 |
Amneal Complex Products Res Llc |
Composiciones farmacéuticas programables para la cronoliberación de fármacos
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
US11547670B2
(en)
|
2019-03-05 |
2023-01-10 |
Amneal Complex Products Research Llc |
Delayed release methylphenidate compositions
|
CN114681422B
(zh)
*
|
2020-12-30 |
2023-09-05 |
深圳翰宇药业股份有限公司 |
一种硝苯地平控释片及其制备方法
|